Evidence map›Paper›PMID 39276041›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2024

[Conbercept reverses TGF-β

M Zhu, J Wang

Abstract readEnglish Abstract
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

M ZhuDepartment of Ophthalmology, Fuyang Hospital of Anhui Medical University, Fuyang 236000, China.
J WangDepartment of Ophthalmology, First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the mechanism by which conbercept reverses transforming growth factor-β

methodsCultured HLEC SRA01/04 cells were treated with TGF-β

resultsConbercept significantly reduced TGF-β

conclusionConbercept inhibits TGF-β

Indexed as

Cell ProliferationEpithelial CellsEpithelial-Mesenchymal TransitionLens, CrystallineSignal TransductionSmad ProteinsTransforming Growth Factor beta2ApoptosisCadherinsCell LineCell MovementHumansSmad2 ProteinTransforming Growth Factor betaCadherinsSmad2 ProteinSmad ProteinsTransforming Growth Factor betaTransforming Growth Factor beta2conberceptepithelial-to-mesenchymal transitionposterior capsule opacificationtransforming growth factor-β2

Identifiers

PMID39276041
PMCPMC11378053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.